Cromolyn sodium Inh Soln Rx
Generic Name and Formulations:
Cromolyn sodium 20mg/2mL; soln for inhalation.
Various generic manufacturers
Indications for Cromolyn sodium Inh Soln:
Asthma prophylaxis. Prevention of bronchoconstriction before exposure to a known precipitant (eg, exercise).
Adults and Children:
<2 years: not recommended. ≥2 years: 20mg administered by power-operated nebulizer 4 times a day. Bronchoconstriction prevention: contents of 1 amp inhaled up to 60 minutes before precipitant.
Not for treatment of acute attack. Impaired renal or hepatic function: reduce dose. Reevaluate if no improvement after 4 weeks. Avoid abrupt cessation. Discontinue if eosinophilic pneumonia occurs. Coronary artery disease or arrhythmias (Inhaler). Pregnancy (Cat.B). Nursing mothers.
Mast cell stabilizer.
Avoid use with isoproterenol during pregnancy.
Bronchospasm, throat irritation, bad taste, cough, wheezing, nasal congestion, anaphylaxis.
Formerly known under the brand name Intal.
Clinical Pain Advisor Articles
- FDA Takes Steps to Reconcile Needs of Patients With Chronic Pain, Efforts to Curb Opioid Epidemic
- History of Migraine May Be Associated With Higher Risk for Cochlear Disorders
- Symptom Severity, Sensory Sensitivity May Indicate Pain Centralization in Chronic Overlapping Pain Conditions
- Stat Consult: Chronic Low Back Pain
- Opioid Misuse May Help Predict Alcohol Dependence Treatment Outcomes
- Consensus Guidelines for the Use of Intravenous Ketamine for Chronic Pain
- Pain Societies Issue Guidelines on Use of Ketamine for the Management of Acute Pain
- Labor Epidural Analgesia Linked to Reduced Likelihood of Successful Breastfeeding
- Novel Oral Treatment Safe, Effective for Migraine Headache Relief
- DFN-02 Nasal Spray Safe, Effective for Acute Treatment of Episodic Migraine
- Predictors of Opioid Overdose in High-Risk Users
- FDA to Review Long-Acting Treatment for Opioid Use Disorder
- Half of Patients Referred for Behavioral Treatment of Migraine Never Initiate Treatment
- Low-Dose Sumatriptan Injection Effective as Acute Migraine Treatment
- The Fight for Patient Privacy Under Big Data Analytics